GT Biopharma, Inc. (GTBP)
0.6608
-0.01
(-1.74%)
USD |
NASDAQ |
Dec 11, 12:30
GT Biopharma Enterprise Value: 4.533M for Dec. 10, 2025
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Plus Therapeutics, Inc. | 75.80M |
| Geron Corp. | 685.93M |
| Regeneron Pharmaceuticals, Inc. | 70.58B |
| SELLAS Life Sciences Group, Inc. | 235.37M |
| Xencor, Inc. | 956.77M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.114M |
| Total Expenses (Quarterly) | 3.114M |
| EPS Diluted (Quarterly) | -0.8268 |
| Earnings Yield | -513.8% |
| Normalized Earnings Yield | -563.04 |